The Reproductive Science Section has a strong, active and historical translational programme involving close interaction between clinical and basic science staff within three main research areas:
- Endocannabinoid Research (Lead: Professor J Konje)
Endocannabinoid research has Medical Research Council, NIHR and industry funding for projects examining the molecular mechanisms and clinical consequences of the endocannabinoid system in reproductive tissues.
Prolapse and Incontinence research is supported by funding from Health Technology Assessment, Wellbeing of Women and the Medical Research Council, and is internationally recognised for its high quality clinical and basic science research in urogynaecology.
- Molecular Cell Signalling (Lead: Dr J Willets)
Molecular Cell Signalling studies molecular mechanisms underlying hypertensive disorders in pregnancy and smooth muscle excitability with relevance to hypertension and in preterm labour.
Other research interests within the Reproductive Sciences Group include;
- Intrauterine infection and feto-placental growth
- Adenomyosis and endometriosis
- Pre-term birth research and reproductive toxicology, especially the effects caffeine and smoking in pregnancy.
Research projects encompassing everything from molecular biology through to multi-centre clinical trials relevant to Reproductive Sciences, are offered as part of our ongoing PhD/MD training programme for clinical and non-clinical researchers. Projects are also available at the undergraduate and post-graduate level, and for intercalated BSc students wishing to pursue an academic career in Obstetrics and Gynaecology.
In May 2013 the Group was successful in its application for a Society for Endocrinology Summer Studentship.